• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经典型毛细胞白血病的非典型脑膜定位对利妥昔单抗和克拉屈滨联合治疗反应显著。一例病例报告及文献综述

Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review.

作者信息

Claves Fabien, Carras Sylvain, Burroni Barbara, Maitre Elsa, Boutonnat Jean, Troussard Xavier, Molina Lysiane

机构信息

Hematology Department University Hospital of Grenoble Alpes Grenoble France.

Grenoble Alpes University Grenoble France.

出版信息

EJHaem. 2024 Jan 9;5(1):242-246. doi: 10.1002/jha2.841. eCollection 2024 Feb.

DOI:10.1002/jha2.841
PMID:38406549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10887254/
Abstract

Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder classically presenting with cytopenia and recurrent infections but atypical manifestations such as bone lesions, skin lesions and effusion have been described. We report here an unusual meningeal localization in a 33 years old man who presented with headache, hand paresthesia and visual symptoms. Brain magnetic resonance imaging revealed an occipital meningeal lesion. Diagnostic explorations led to the diagnosis of classical HCL with meningeal localization. After treatment by cladribine and rituximab the patient rapidly improved and is still in complete remission 12 months after end of treatment. The literature review identified 9 other cases of HCL with central nervous system localization (CNS) presenting with brain parenchyma and/or meninges localization. Four out of 9 patients presented with hyperleukocytosis. Most patients experienced good responses with various treatments. Cladribine alone or with rituximab led to complete responses similar to our patient. In our patient, molecular biology revealed KLF2 mutations, which implication in the atypical localization could be suspected but would need dedicated studies. In conclusion, CNS localizations of HCL are rare but can be observed and treatment with cladribine alone or with rituximab appears as an effective strategy.

摘要

毛细胞白血病(HCL)是一种罕见的淋巴增殖性疾病,典型表现为血细胞减少和反复感染,但也有诸如骨病变、皮肤病变和积液等非典型表现的报道。我们在此报告一例33岁男性患者的不寻常脑膜定位情况,该患者表现为头痛、手部感觉异常和视觉症状。脑部磁共振成像显示枕部脑膜病变。诊断性检查确诊为伴有脑膜定位的经典型HCL。经克拉屈滨和利妥昔单抗治疗后,患者迅速好转,治疗结束12个月后仍处于完全缓解状态。文献回顾发现另外9例中枢神经系统(CNS)定位的HCL病例,表现为脑实质和/或脑膜定位。9例患者中有4例出现白细胞增多。大多数患者经各种治疗后反应良好。单独使用克拉屈滨或联合利妥昔单抗治疗导致完全缓解,与我们的患者情况相似。在我们的患者中,分子生物学检测发现KLF2突变,其在非典型定位中的作用值得怀疑,但需要专门研究。总之,HCL的CNS定位罕见,但可以观察到,单独使用克拉屈滨或联合利妥昔单抗治疗似乎是一种有效的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0a/10887254/a6c6b0b83afa/JHA2-5-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0a/10887254/a6c6b0b83afa/JHA2-5-242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c0a/10887254/a6c6b0b83afa/JHA2-5-242-g001.jpg

相似文献

1
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review.经典型毛细胞白血病的非典型脑膜定位对利妥昔单抗和克拉屈滨联合治疗反应显著。一例病例报告及文献综述
EJHaem. 2024 Jan 9;5(1):242-246. doi: 10.1002/jha2.841. eCollection 2024 Feb.
2
Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib.病例报告:1例中枢神经系统受累的经典毛细胞白血病患者接受维莫非尼治疗。
Front Oncol. 2023 Jan 12;12:1100577. doi: 10.3389/fonc.2022.1100577. eCollection 2022.
3
Long-term follow-up of patients with hairy cell leukemia in the south of Iran.伊朗南部毛细胞白血病患者的长期随访。
Expert Rev Hematol. 2023 Apr;16(4):289-295. doi: 10.1080/17474086.2023.2174520. Epub 2023 Feb 12.
4
Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.毛细胞白血病患者接受克拉屈滨序贯利妥昔单抗治疗后的长期持久缓解:一项II期试验的更新
Br J Haematol. 2016 Sep;174(5):760-6. doi: 10.1111/bjh.14129. Epub 2016 Jun 15.
5
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.随机Ⅱ期研究:一线 cladribine 联合或不联合利妥昔单抗治疗毛细胞白血病患者。
J Clin Oncol. 2020 May 10;38(14):1527-1538. doi: 10.1200/JCO.19.02250. Epub 2020 Feb 28.
6
Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.利妥昔单抗治疗毛细胞白血病变异型:一例报告
Prilozi. 2008 Dec;29(2):355-60.
7
Bullous Pyoderma Gangrenosum Associated with Hairy Cell Leukemia and Its Complete Response to Cladribine Therapy.大疱性坏疽性脓皮病与毛细胞白血病相关及其对克拉屈滨治疗的完全缓解
Indian J Hematol Blood Transfus. 2017 Jun;33(2):273-275. doi: 10.1007/s12288-016-0713-8. Epub 2016 Aug 11.
8
[Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine].24例毛细胞白血病患者接受克拉屈滨治疗的临床分析
Zhonghua Xue Ye Xue Za Zhi. 2018 Jun 14;39(6):491-495. doi: 10.3760/cma.j.issn.0253-2727.2018.06.011.
9
My treatment approach to hairy cell leukemia.我治疗毛细胞白血病的方法。
Mayo Clin Proc. 2012 Jan;87(1):67-76. doi: 10.1016/j.mayocp.2011.09.001.
10
Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.利妥昔单抗成功诱导一名难治性日本变异型毛细胞白血病患者实现长期缓解。
Int J Hematol. 2004 Dec;80(5):432-4. doi: 10.1532/ijh97.04078.

引用本文的文献

1
Rare Clinical Symptoms in Hairy Cell Leukemia: An Overview.毛细胞白血病的罕见临床症状:概述
Cancers (Basel). 2024 Sep 1;16(17):3054. doi: 10.3390/cancers16173054.
2
Extramedullary Paravertebral Mass: An Unusual Presentation of Hairy Cell Leukaemia.椎旁髓外肿块:毛细胞白血病的一种不寻常表现
Eur J Case Rep Intern Med. 2024 Jul 26;11(8):004707. doi: 10.12890/2024_004707. eCollection 2024.

本文引用的文献

1
A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.成熟 B 细胞淋巴瘤的国际共识与第 5 版世界卫生组织分类的比较。
Leukemia. 2023 Jan;37(1):18-34. doi: 10.1038/s41375-022-01764-1. Epub 2022 Dec 2.
2
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.解析98例毛细胞白血病及毛细胞白血病样疾病的基因改变
Cancers (Basel). 2022 Apr 10;14(8):1904. doi: 10.3390/cancers14081904.
3
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
毛细胞白血病 2022:诊断、风险分层和治疗的更新。
Am J Hematol. 2022 Feb 1;97(2):226-236. doi: 10.1002/ajh.26390. Epub 2021 Nov 8.
4
Skin changes in hairy cell leukemia.毛发细胞白血病的皮肤改变。
Ann Hematol. 2021 Mar;100(3):615-625. doi: 10.1007/s00277-020-04349-z. Epub 2020 Nov 20.
5
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.分析 279 例毛细胞白血病(HCL)患者队列:10 年随访结果。
Blood Cancer J. 2020 May 27;10(5):62. doi: 10.1038/s41408-020-0328-z.
6
Atypical presentation of hairy cell leukemia: a report and comprehensive review.毛细胞白血病的非典型表现:病例报告及全面综述
Blood Res. 2020 Jun 30;55(2):123-127. doi: 10.5045/br.2020.2020069.
7
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia.487 例毛细胞白血病患者的长期随访和第二恶性肿瘤。
Br J Haematol. 2014 Aug;166(3):390-400. doi: 10.1111/bjh.12908. Epub 2014 Apr 18.
8
Krüppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression.Krüppel 样因子 2(KLF2)调节 B 细胞反应性、亚群分化和趋化因子表达。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):716-21. doi: 10.1073/pnas.1013168108. Epub 2010 Dec 27.